GeneOhm Sciences

GeneOhm Sciences, Inc.GeneOhm Sciences, Inc. specializes in molecular diagnostics, focusing on rapid testing solutions. In February 2006, the company was acquired by Becton, Dickinson and Company. The headquarters is located in San Diego, US. The founder's history and prior ventures are not specified., a fully integrated, automated molecular platform designed for nucleic acid extraction and real-time PCR testing. The platform enhances laboratory efficiency by delivering timely and accurate results for up to 24 samples within approximately three hours.BD MAX™ employs a business-to-business (B2B) model, generating revenue through direct sales agreements with healthcare providers and laboratories. Revenue streams include the sale of diagnostic systems and assays, such as the BD MAX™ Vaginal Panel and BD MAX™ MRSA XT Panel.Looking ahead, GeneOhm Sciences, Inc. intends to launch new diagnostic products aimed at expanding its portfolio in the molecular diagnostics market. Additionally, the company is exploring opportunities to expand into new geographic markets, although specific regions have not been disclosed. The strategic growth plan aims to increase market share and improve accessibility to its diagnostic solutions.

1. Series C

   Jan 18, 2005

   Amount

   $14M

   Investors

   Locked

2. Series C

   Nov 24, 2004

   Amount

   $12M

   Investors

   Locked

3. Series B

   Jan 1, 2003

   Amount

   $12M

   Investors

   Locked